Neurodon
Neurodon is a biopharmaceutical company with small molecules in IND-enabling studies for type 1 and type 2 diabetes and Alzheimer's disease.
Neurodon operates in biotechnology, health care, medical, pharmaceutical based in Greater Chicago Area, Great Lakes, Midwestern US, founded in 2017.
As a business in biotechnology, health care, medical, pharmaceutical, Neurodon is listed here with the public details available about it.
The company is recorded as being based in Greater Chicago Area, Great Lakes, Midwestern US.
Directory data places it at the Grant stage.
The company reports a headcount in the c_00001_00010 range.
It has disclosed roughly $9.4M in funding.
| Sector | Biotechnology, Health Care, Medical, Pharmaceutical |
|---|---|
| Headquarters | Greater Chicago Area, Great Lakes, Midwestern US |
| Founded | 2017 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $9,445,000 |
Website: neurodon.net
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account